Outcomes were either ΔDAS28 at 3 or 6 months, or the EULAR criteria, which were used as a comparison of non-responders (NR) with responders (good + moderate responders (GR + M)) at 3 months, or a comp
Hypothetical clinical dataset to support the manuscript entitled "A quantitative method for measuring the relationship between an objective endpoint and patient reported outcome measures"